CureGN (Glomerulonephropathy)
A study of glomerular disease patients to better understand the causes of the disease, response to therapy, and disease progression.
A study of glomerular disease patients to better understand the causes of the disease, response to therapy, and disease progression.
This study will evaluate the effect of Denosumab on lumbar spine mineral density (BMD), as assessed by dual-energy X-Ray absorptiometry (DEXA) at 12 months in children 5 to 17 years of age with GIOP.
To advance research on Minimal Change Disease (MCD), Focal and Segmental Glomerulosclerosis (FSGS), and Membranous Nephropathy (MN) that define nephrotic syndrome.
Understand the experiences of patients and parents in treatment decision making for children with Neuromuscular Scoliosis (NMS).